深振業A(000006.SZ):擬開展住房尾款資產支持證券業務 融資總規模不超5億元
格隆匯8月4日丨深振業A(000006.SZ)公佈,為了盤活存量資產、拓寬融資渠道,提高資產的流動性,增強現金流的穩定性,公司將作為原始權益人開展住房尾款資產支持證券業務,通過設立“資產支持專項計劃”,發行資產支持證券進行融資,計劃融資總規模不超過5億元(發行總規模等項目相關要素可能因監管機構要求或市場需求進行調整),融資期限不超過2年(具體期限根據基礎資產特定期間及發行時間最終確定)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.